Klick Health

FDA DRAFT GUIDANCE

CORRECTING THIRD-PARTY MISINFORMATION ON SOCIAL PLATFORMS

This draft guidance tells pharmaceutical and medtech manufacturers that they can correct information as long as they adhere to “medical information” best practices and avoid any and all “marketing” content. No monitoring of content is expected and firms need only keep records of their actions, they do not need to report those actions proactively to the FDA.

  • What does this mean for healthcare marketers?
  • How do you handle content responsibility?
  • How do you correct missinformation?

Please fill out the form below to receive our guide:

Sign up to receive your copy of the POV

* All fields are required

Share on Social Media